Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Gut Microbe-Derived Molecule Halves Artery Plaque in Mice

2w ago October 14, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Researchers discovered that a common gut bacterium produces a molecule that significantly reduces fatty plaque in mice prone to artery disease. This finding could have implications for health and medical research in Iran, particularly in addressing cardiovascular diseases. Understanding gut microbiomes may lead to new treatments that could benefit the Iranian population.

🔍 Quick Context Guide
💡 Bottom Line: The discovery of a gut-derived molecule that reduces artery plaque could pave the way for innovative treatments for heart disease.

👥 Key Players

Researchers MENTIONED
Scientists conducting the study
"Their findings could lead to new health interventions for cardiovascular diseases, which are prevalent in Iran."

📰 What Happened

Researchers found that a molecule produced by a common gut bacterium can significantly reduce fatty plaque in mice that are prone to artery disease. This discovery suggests potential new avenues for treating cardiovascular conditions.

  • The molecule slows cholesterol production in the liver.
  • Mice treated with the molecule developed half as much fatty plaque compared to untreated mice.

💡 Why It Matters

🇮🇷 For Iran: This research could lead to new treatments for cardiovascular diseases, which are a leading cause of death in Iran.
🌍 Regional: If successful, it could enhance regional health outcomes and reduce healthcare costs associated with heart diseases.
🌐 International: The findings may attract international interest in microbiome research and its applications in medicine.

📚 Background

Gut microbiomes are increasingly recognized for their role in human health, influencing various conditions including heart disease. Understanding these relationships can lead to novel therapeutic strategies.

Gut microbiome research Cardiovascular disease treatments
📡 Source: NEUTRAL
📊 Confidence: 70%
The article presents scientific findings without apparent bias, focusing on research implications.

A common gut bacterium produces a molecule that slows cholesterol production in the liver. When researchers gave the molecule to mice prone to artery disease, the animals developed roughly half as much fatty plaque as untreated controls.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →